Docstoc

An Open

Document Sample
An Open Powered By Docstoc
					(An Open-ended Pharma Sector Scheme.) The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities
of Pharma and other associated companies.


Related Links
    Fund Manager Addenda          KIM cum Application Form


Latest NAVs

Scheme                                                                  Current NAV          Nav Date

  Dividend Plan                                                          36.0058 26 Mar 2010
  Growth Plan Bonus Option                                               48.2784 26 Mar 2010
  Growth Plan Growth Option                                              48.2784 26 Mar 2010
                                                                               Performance as on 26/02/2010
                                                                                Absolute                                               Compounded Annualized
                                                                                 6 months                1 year               3 year               5 year                Since Inception
  Reliance Pharma Fund - Growth                                                     34.82                147.43               29.08                28.25                     29.17
  BSE-HC                                                                            26.09                88.44                10.68                13.53                     14.67


Past             Performance                may               or             may                not               be          sustained                      in           the           future.
Aforesaid       returns      are           Compounded          annualized       returns         in      %           of     Growth       Option.                (Inception     Date:08/06/2004)
Calculations   assume that all           payouts during      the period      have been        reinvested in       the units of the scheme                   at the then prevailing NAV.

Product                                                                                                                                                                                    Features

Investment Objective - The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of
Pharma                                   and                                      other                                      associated                                     companies

Asset Allocation


                                                                                                                                   Indicative asset allocation
                                              Types of Instruments                                                                                                             Risk Profile
                                                                                                                                       (% of total assets)
                                                                                                                            Maximum       Most Likely       Minimum
  Equity and Equity related Instruments                                                                                       100%                80%              0%         High to Medium
  Debt Instruments & Money Market Instruments with an average maturity OF 5-10 yrs                                            100%                20%               0%        Medium to Low
Securitised                    debt                         upto                                100%                             of                               the                    corpus.

However, the above is only indicative and the AMC reserves the right to change the profile based on market outlook and the interest rate scenario.

Fund                                Manager -                                 Mr.                                 Sailesh                                   Raj                               Bhan

Plans                                                                                                                                                                                  Available
Growth                           Plan:                        Growth                           Option                           &                            Bonus                       Option
Dividend                 Plan:               Dividend              payout                   Option                &                    Dividend               Reinvestment               Option

Benchmark                                 Index -                              BSE                                 Health                                   Care                              Index

Minimum                                                                                  Application                                                                                    Amount
Rs                     5000                  and                   in                    multiples                     of                    Re.                     1                 thereafter

Minimum                                                     additional                                                       purchase                                                    amount
Rs                     1000                  and                   in                    multiples                     of                    Re.                     1                 thereafter

Load Structure:
  Entry Load                      In terms of SEBI circular no. SEBI/IMD/CIR No.4/ 168230/09 dated June 30, 2009, no entry load will be charged by the Scheme to the                  Nil
                                  investor effective August 1, 2009. Upfront commission shall be paid directly by the investor to the AMFI registered Distributors based on
                                  the investors' assessment of various factors including the service rendered by the distributor


  Exit Load

                                  If redeemed or switched out on or before completion of 1 year from the date of allotment of units.                                                  1%
                                  If redeemed or switched out after completion of 1 year from the date of allotment of units                                                          Nil

Facilities Available
  Systematic Investment Plan
  Systematic Transfer Plan
  Systematic Withdrawal Plan
  Reliance Salary AddVantage
  Dividend Transfer Plan
  Recurring Investment Plan for Corporate Employees
  Trigger Facility
  Online Transaction
  Reliance SIP Insure
  Auto Debit & Electronic Clearing System

Applicable                                                                                                                                                                               NAVs
Subscriptions/Purchases                                        including                                   switch                                    -                                     ins:
In respect of valid applications received upto 3 p.m. by the Mutual Fund alongwith a local cheque or a demand draft payable at par at the place where the application is received, the closing
NAV               of            the            day            on           which             application          is            received            shall            be             applicable.
In respect of valid applications received after 3 p.m. by the Mutual Fund alongwith a local cheque or a demand draft payable at par at the place where the application is received, the closing
NAV                      of                  the                  next                  business                 day                    shall                 be                    applicable.

Redemptions                               including                        switch                          -                               outs:
In respect of valid applications received upto 3 p.m. by the Mutual Fund, closing NAV of the day of receipt of application, shall be applicable.
In respect of valid applications received after 3 p.m. by the Mutual Fund, the closing NAV of the next business day shall be applicable.

Disclaimer
Sponsor: Reliance Capital Limited. Trustee: Reliance Capital Trustee Co. Limited. Investment Manager:Reliance Capital Asset Management Limited. Statutory Details: The Sponsor,
the        Trustee        and         the         Investment         Manager          are      incorporated        under        the       Companies          Act         1956.

Risk                                                                                                                                                                                  Factors
Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the Scheme will be achieved. As with any
investment in securities, the NAV of the Units issued under the Scheme can go up or down depending on the factors and forces affecting the capital markets. Past performance of
the Sponsor/AMC/Mutual Fund is not indicative of the future performance of the Scheme. The Sponsor is not responsible or liable for any loss resulting from the operation of the Scheme
beyond their initial contribution of Rs.1 lakh towards the setting up of the Mutual Fund and such other accretions and additions to the corpus. Reliance Pharma Fund is the name of the
Scheme and does not in any manner indicate either the quality of the Scheme; its future prospects or returns.The NAV of the Scheme may be affected, interalia, by changes in the
market conditions, interest rates, trading volumes, settlement periods and transfer procedures. The Mutual Fund is not assuring that it will make periodical dividend distributions, though it
has every intention of doing so. All dividend distributions are subject to the availability of distributable surplus in the Scheme. Please read the Statement of Additional Information and
Scheme Information Document carefully before investing.

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:12
posted:3/29/2010
language:English
pages:2